This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other sex chromosome abnormalities, female phenotype, not elsewhere classified
Q17_OTHER_SEX_CHROMOSOME_ABNORMALITI_FEMALE_PHENOT_NOT_ELSEW_CLASSIFIED
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
32 |
4. Check minimum number of eventsNone |
32 |
5. Include endpointsNone |
32 |
6. Filter based on genotype QC (FinnGen only) |
32 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CHROMOSOMAL_ABNORMALITI_NOT_ELSEW_CLASSIFIED
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q9
- Name in latin
- Aliae abnormitates chromosomatum sexualium patientis phaenotypo femininae non alibi classificatae
Similar endpoints
↥List of similar endpoints to
Other sex chromosome abnormalities, female phenotype, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Chromosomal abnormalities, not elsewhere classified
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 332 | 301 | 29 |
| Only index persons | 280 | 253 | 27 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 13.08 | 12.98 | 12.74 |
| Only index persons | 16.23 | 16.31 | 15.49 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 32 | 32 | - |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | - |
| Median age at first event (years) | 32.08 | 32.08 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42870588) Differential panel, method unspecified - Blood
18
88
3.39
2.83
10.4
5.9
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
6
14
5.00
2.27
1.2
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
17
4.09
1.94
1.3
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
7
25
3.29
1.77
5.1
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
6
23
2.97
1.44
4.2
3.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
8
34
2.79
1.41
5.0
2.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
23
166
2.37
1.40
12.2
6.1
u/l
78.4
80.8
0.12
18
155
(3000492) Spirometry study
5
19
2.92
1.26
1.2
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
21
2.63
1.13
1.8
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
14
87
2.08
1.12
2.1
1.4
u/ml
0.4
0.6
—
5
20
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
22
2.50
1.07
1.8
1.2
—
—
—
0
0
(3012544) pH of Venous blood
0
28
0.00
1.03
0.0
5.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
27
2.50
1.00
2.0
2.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
13
82
1.99
0.97
2.4
2.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
13
83
1.95
0.93
4.0
3.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
6
31
2.15
0.90
1.7
2.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
0
26
0.00
0.82
0.0
5.6
—
5.0
—
0
26
(3021447) Carbon dioxide [Partial pressure] in Venous blood
0
27
0.00
0.81
0.0
5.7
—
5.8
—
0
27
(3002032) Base excess in Venous blood by calculation
0
27
0.00
0.81
0.0
5.7
—
1.6
—
0
19
(3028300) Cannabinoids [Presence] in Urine
5
24
2.28
0.78
1.8
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
24
2.28
0.78
1.8
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
25
2.18
0.76
1.8
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
25
2.18
0.76
1.8
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
11
71
1.84
0.74
5.4
3.2
estimate
0.0
0.0
—
6
24
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
27
2.00
0.72
1.4
1.9
—
—
—
0
0
(3015736) pH of Urine
15
109
1.71
0.68
4.2
2.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
0
20
0.00
0.63
0.0
2.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
0
20
0.00
0.63
0.0
6.5
—
24.1
—
0
20
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
9
59
1.73
0.62
1.9
2.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
21
0.00
0.62
0.0
1.3
—
233.8
—
0
10
(3023368) Bacteria identified in Blood by Culture
6
37
1.76
0.59
6.2
4.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
23
195
1.64
0.59
11.0
3.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
64
1.56
0.58
1.2
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6
39
1.66
0.56
1.8
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
27
239
1.83
0.55
3.3
2.7
mmol/l
5.9
5.3
0.48
21
224
(3013512) EKG study
7
44
1.75
0.54
2.0
2.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
102
0.60
0.50
1.9
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
12
88
1.58
0.49
5.7
2.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
10
70
1.62
0.49
7.8
6.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
14
107
1.55
0.48
5.4
2.9
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
8
58
1.50
0.46
4.4
3.4
%
92.9
90.2
—
8
58
(36304419) Bacteria [Presence] in Urine
10
71
1.59
0.46
2.9
3.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
17
137
1.51
0.46
6.1
4.4
estimate
0.0
0.0
—
6
25
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
32
1.66
0.44
1.6
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
16
128
1.50
0.44
3.9
4.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
17
138
1.49
0.43
4.8
2.9
estimate
0.0
0.0
—
5
26
(3000330) Specific gravity of Urine by Test strip
0
15
0.00
0.42
0.0
1.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
0
16
0.00
0.42
0.0
12.6
—
9.4
—
0
16
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
0
17
0.00
0.42
0.0
1.4
—
88.6
—
0
7
(21494755) Public health laboratory ask at order entry panel
5
36
1.46
0.40
1.6
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
17
140
1.46
0.39
4.8
3.1
estimate
0.0
0.0
—
6
25
(3019198) Lymphocytes [#/volume] in Blood
18
150
1.46
0.39
12.2
5.2
e9/l
2.3
2.0
1.14
18
135
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
6
44
1.45
0.37
1.2
1.3
—
3.4
—
0
17
(3023103) Potassium [Moles/volume] in Serum or Plasma
27
251
1.48
0.30
24.7
10.2
mmol/l
3.8
3.9
0.33
27
243
(1761868) Lipid panel - Serum or Plasma
8
102
0.71
0.26
3.5
2.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
0
11
0.00
0.22
0.0
14.9
—
1.4
—
0
11
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
10
0.00
0.22
0.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
10
0.00
0.22
0.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
6
49
1.28
0.21
1.8
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
66
0.71
0.19
1.2
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
16
141
1.27
0.19
4.1
2.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
8
69
1.21
0.18
8.3
3.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
78
0.72
0.18
1.7
2.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
25
233
1.33
0.17
3.8
2.9
mmol/l
2.7
2.8
0.13
20
219
(3003694) ABO and Rh group [Type] in Blood
13
113
1.25
0.16
1.5
2.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
54
1.14
0.09
1.2
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
8
72
1.15
0.08
2.0
2.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
24
231
1.16
0.08
4.1
2.9
mmol/l
1.4
1.5
0.80
19
219
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
9
99
0.87
0.07
1.3
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
23
222
1.13
0.07
3.7
2.7
mmol/l
1.3
1.1
0.83
18
208
(40768804) Tissue Pathology biopsy report
11
101
1.14
0.05
2.6
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
13
122
1.11
0.03
1.5
2.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
105
0.93
0.00
1.2
2.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
0.0
—
0
5
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(4211845)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
0
7
0.00
0.00
0.0
2.9
—
0.8
—
0
7
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
6.2
—
70.8
—
0
5
(3025130) Human papilloma virus identified in Specimen
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
9
0.00
0.00
0.0
3.8
—
37.8
—
0
9
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
0.0
—
0
5
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
0
8
0.00
0.00
0.0
2.6
—
2.2
—
0
8
(3020630) Protein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
70.3
—
0
7
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
2.9
—
0
5
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
103.2
—
0
5
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
3.8
—
0
5
(3004119) Hemoglobin [Mass/volume] in Venous blood
0
9
0.00
0.00
0.0
2.8
—
132.3
—
0
9
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
2.2
—
104.2
—
0
5
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
0.0
—
0
5
(42529406) Shigella sp [Presence] in Stool by Culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
6.2
—
0
5
(3020891) Body temperature
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
10.7
—
0
5
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
3.5
—
0
5
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
2.0
—
0
5
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.3
—
51.7
—
0
7
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
86
0.91
0.00
1.3
2.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
9
95
0.93
0.00
1.6
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
41.0
—
0
5
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
18.5
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_SEX_CHROMOSOME_ABNORMALITI_FEMALE_PHENOT_NOT_ELSEW_CLASSIFIED and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_OTHER_SEX_CHROMOSOME_ABNORMALITI_FEMALE_PHENOT_NOT_ELSEW_CLASSIFIED.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_SEX_CHROMOSOME_ABNORMALITI_FEMALE_PHENOT_NOT_ELSEW_CLASSIFIED – Other sex chromosome abnormalities, female phenotype, not elsewhere classified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data